UK Faces Significant Aspirin Shortage, Warn Pharmacists

Jordan Hartwell

ago 1 hour

UK Faces Significant Aspirin Shortage, Warn Pharmacists

The United Kingdom is currently facing a significant shortage of aspirin, raising concerns among pharmacists regarding patient care. The National Pharmacy Association (NPA) has expressed alarm over these developments, highlighting the impact on patients who rely on this essential medication.

Aspirin Usage in the UK

Between January and October 2022, there were 51 million aspirin prescriptions filled in the U.K. This figure underscores the medication’s critical role in healthcare for various conditions, particularly cardiovascular health.

Pharmacists’ Frustrations

Olivier Picard, chair of the NPA, stated that the ongoing supply issues are causing significant distress among pharmacies. Those able to source aspirin are facing exorbitant costs that surpass the reimbursement rates from the National Health Service (NHS).

Government Response

The UK government has been urged to reform the pharmacy contract to address these shortages.
Pharmacists currently cannot substitute medications without a new prescription, which adds to the difficulties for patients.
On January 16th, the government placed aspirin on its export ban list to manage the domestic shortage.

European Context

In contrast to the situation in the UK, the Pharmaceutical Group of the European Union recently stated that they have not reported any aspirin shortages within the EU. Furthermore, the European Medicines Agency has not placed aspirin on its list of drugs in short supply.

Potential Changes Ahead

There is ongoing discussion about allowing pharmacists to make medication substitutions in cases where a prescribed drug is unavailable. According to Picard, this change could significantly benefit both patients and pharmacists alike. Ensuring safe alternatives could alleviate some pressure caused by the current shortage.

The situation surrounding the aspirin shortage in the UK emphasizes the urgent need for reform. Without timely action, patients may continue to experience challenges in accessing this vital medication.